The SURMOUNT program, the SURPASS program for diabetes, the SUMMIT cardiovascular trial, and the phase 2 type 1 diabetes trial collectively represent one of the most extensive evidence bases for any weight loss intervention in history
Additionally, women have unique safety considerations regarding pregnancy, as the FDA requires stopping Wegovy at least two months before trying to become pregnant due to potential risks to an unborn baby
This 2 months plans saves you over $200 as compared to if you do month to month dose increase plan
The worry around cancer mostly stems from BPC-157s ability to support angiogenesis, or the growth of new blood vessels
Schedule your consultation today to kick-start your journey.
To report suspected adverse reactions to o semaglutide, contact the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch